Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 73 to 81 of 81 entries
Sorted by: Best Match Show Resources per page
Propranolol-induced Impairment of Contextual Fear Memory Reconsolidation in Rats: A similar Effect on Weak and Strong Recent and Remote Memories.

Basic and clinical neuroscience

Taherian F, Vafaei AA, Vaezi GH, Eskandarian S, Kashef A, Rashidy-Pour A.
PMID: 25337385
Basic Clin Neurosci. 2014;5(3):231-9.

INTRODUCTION: Previous studies have demonstrated that the β-adrenergic receptor antagonist propranolol impairs fear memory reconsolidation in experimental animals. There are experimental parameters such as the age and the strength of memory that can interact with pharmacological manipulations of memory...

Cite
Taherian F, Vafaei AA, Vaezi GH, et al. Propranolol-induced Impairment of Contextual Fear Memory Reconsolidation in Rats: A similar Effect on Weak and Strong Recent and Remote Memories. Basic Clin Neurosci. 2014;5(3):231-9
Taherian, F., Vafaei, A. A., Vaezi, G. H., Eskandarian, S., Kashef, A., & Rashidy-Pour, A. (2014). Propranolol-induced Impairment of Contextual Fear Memory Reconsolidation in Rats: A similar Effect on Weak and Strong Recent and Remote Memories. Basic and clinical neuroscience, 5(3), 231-9.
Taherian, Fatemeh, et al. "Propranolol-induced Impairment of Contextual Fear Memory Reconsolidation in Rats: A similar Effect on Weak and Strong Recent and Remote Memories." Basic and clinical neuroscience vol. 5,3 (2014): 231-9.
Taherian F, Vafaei AA, Vaezi GH, Eskandarian S, Kashef A, Rashidy-Pour A. Propranolol-induced Impairment of Contextual Fear Memory Reconsolidation in Rats: A similar Effect on Weak and Strong Recent and Remote Memories. Basic Clin Neurosci. 2014;5(3):231-9. PMID: 25337385; PMCID: PMC4202546.
Copy Download .nbib Format: NLM
Using Amniotic Membrane as a Novel Method to Reduce Post-burn Hypertrophic Scar Formation: A Prospective Follow-up Study.

Journal of cutaneous and aesthetic surgery

Mohammadi AA, Eskandari S, Johari HG, Rajabnejad A.
PMID: 28529415
J Cutan Aesthet Surg. 2017 Jan-Mar;10(1):13-17. doi: 10.4103/JCAS.JCAS_109_16.

BACKGROUND: Several studies have shown that the application of amniotic membrane as a biological dressing in the management of burns is accompanied by rapid re-epithelialisation. In this follow-up study, we aimed to evaluate the possible role of amniotic membrane...

Cite
Mohammadi AA, Eskandari S, Johari HG, et al. Using Amniotic Membrane as a Novel Method to Reduce Post-burn Hypertrophic Scar Formation: A Prospective Follow-up Study. J Cutan Aesthet Surg. 2017;10(1):13-17doi: 10.4103/JCAS.JCAS_109_16.
Mohammadi, A. A., Eskandari, S., Johari, H. G., & Rajabnejad, A. (2017). Using Amniotic Membrane as a Novel Method to Reduce Post-burn Hypertrophic Scar Formation: A Prospective Follow-up Study. Journal of cutaneous and aesthetic surgery, 10(1), 13-17. https://doi.org/10.4103/JCAS.JCAS_109_16
Mohammadi, Ali Akbar, et al. "Using Amniotic Membrane as a Novel Method to Reduce Post-burn Hypertrophic Scar Formation: A Prospective Follow-up Study." Journal of cutaneous and aesthetic surgery vol. 10,1 (2017): 13-17. doi: https://doi.org/10.4103/JCAS.JCAS_109_16
Mohammadi AA, Eskandari S, Johari HG, Rajabnejad A. Using Amniotic Membrane as a Novel Method to Reduce Post-burn Hypertrophic Scar Formation: A Prospective Follow-up Study. J Cutan Aesthet Surg. 2017 Jan-Mar;10(1):13-17. doi: 10.4103/JCAS.JCAS_109_16. PMID: 28529415; PMCID: PMC5418975.
Copy Download .nbib Format: NLM
Characteristics of COVID-19 in patients with multiple sclerosis.

Multiple sclerosis and related disorders

Ghadiri F, Sahraian MA, Shaygannejad V, Ashtari F, Ghalyanchi Langroodi H, Baghbanian SM, Mozhdehipanah H, Majdi-Nasab N, Hosseini S, Poursadeghfard M, Beladimoghadam N, Razazian N, Ayoubi S, Rezaeimanesh N, Eskandarieh S, Naser Moghadasi A.
PMID: 34896875
Mult Scler Relat Disord. 2021 Nov 30;57:103437. doi: 10.1016/j.msard.2021.103437. Epub 2021 Nov 30.

BACKGROUND: Regarding the high prevalence of multiple sclerosis (MS) and COVID-19 in Iran, a multicenter study of COVID-19 in Iranian MS patients with is carried out to address the concerns of this population.METHODS: Data on MS patients with COVID-19...

Cite
Ghadiri F, Sahraian MA, Shaygannejad V, et al. Characteristics of COVID-19 in patients with multiple sclerosis. Mult Scler Relat Disord. 2021;57:103437doi: 10.1016/j.msard.2021.103437.
Ghadiri, F., Sahraian, M. A., Shaygannejad, V., Ashtari, F., Ghalyanchi Langroodi, H., Baghbanian, S. M., Mozhdehipanah, H., Majdi-Nasab, N., Hosseini, S., Poursadeghfard, M., Beladimoghadam, N., Razazian, N., Ayoubi, S., Rezaeimanesh, N., Eskandarieh, S., & Naser Moghadasi, A. (2021). Characteristics of COVID-19 in patients with multiple sclerosis. Multiple sclerosis and related disorders, 57103437. https://doi.org/10.1016/j.msard.2021.103437
Ghadiri, Fereshteh, et al. "Characteristics of COVID-19 in patients with multiple sclerosis." Multiple sclerosis and related disorders vol. 57 (2021): 103437. doi: https://doi.org/10.1016/j.msard.2021.103437
Ghadiri F, Sahraian MA, Shaygannejad V, Ashtari F, Ghalyanchi Langroodi H, Baghbanian SM, Mozhdehipanah H, Majdi-Nasab N, Hosseini S, Poursadeghfard M, Beladimoghadam N, Razazian N, Ayoubi S, Rezaeimanesh N, Eskandarieh S, Naser Moghadasi A. Characteristics of COVID-19 in patients with multiple sclerosis. Mult Scler Relat Disord. 2021 Nov 30;57:103437. doi: 10.1016/j.msard.2021.103437. Epub 2021 Nov 30. PMID: 34896875; PMCID: PMC8629769.
Copy Download .nbib Format: NLM
Prevalence of Multiple sclerosis and its clinical and demographic characteristics in Kurdish populations in western Iran (2020).

Multiple sclerosis and related disorders

Razazian N, Eskandarieh S, Siabani S, Afshari D, Sahraian MA, Khezri O, Rezaei M, Fakhri N.
PMID: 34896874
Mult Scler Relat Disord. 2021 Dec 04;57:103441. doi: 10.1016/j.msard.2021.103441. Epub 2021 Dec 04.

BACKGROUND: Multiple Sclerosis (MS) is a costly burdensome nervous system disorder leading several disabilities in young and middle-aged people. Knowing MS clinical, epidemiologic and demographic characteristics may help to estimate and predict the required health services and medication facilities...

Cite
Razazian N, Eskandarieh S, Siabani S, et al. Prevalence of Multiple sclerosis and its clinical and demographic characteristics in Kurdish populations in western Iran (2020). Mult Scler Relat Disord. 2021;57:103441doi: 10.1016/j.msard.2021.103441.
Razazian, N., Eskandarieh, S., Siabani, S., Afshari, D., Sahraian, M. A., Khezri, O., Rezaei, M., & Fakhri, N. (2021). Prevalence of Multiple sclerosis and its clinical and demographic characteristics in Kurdish populations in western Iran (2020). Multiple sclerosis and related disorders, 57103441. https://doi.org/10.1016/j.msard.2021.103441
Razazian, Nazanin, et al. "Prevalence of Multiple sclerosis and its clinical and demographic characteristics in Kurdish populations in western Iran (2020)." Multiple sclerosis and related disorders vol. 57 (2021): 103441. doi: https://doi.org/10.1016/j.msard.2021.103441
Razazian N, Eskandarieh S, Siabani S, Afshari D, Sahraian MA, Khezri O, Rezaei M, Fakhri N. Prevalence of Multiple sclerosis and its clinical and demographic characteristics in Kurdish populations in western Iran (2020). Mult Scler Relat Disord. 2021 Dec 04;57:103441. doi: 10.1016/j.msard.2021.103441. Epub 2021 Dec 04. PMID: 34896874.
Copy Download .nbib Format: NLM
The potential of intrinsically disordered regions in vaccine development.

Expert review of vaccines

Ameri M, Nezafat N, Eskandari S.
PMID: 34693831
Expert Rev Vaccines. 2022 Jan;21(1):1-3. doi: 10.1080/14760584.2022.1997600. Epub 2021 Nov 15.

No abstract available.

Cite
Ameri M, Nezafat N, Eskandari S. The potential of intrinsically disordered regions in vaccine development. Expert Rev Vaccines. 2021;21(1):1-3doi: 10.1080/14760584.2022.1997600.
Ameri, M., Nezafat, N., & Eskandari, S. (2022). The potential of intrinsically disordered regions in vaccine development. Expert review of vaccines, 21(1), 1-3. https://doi.org/10.1080/14760584.2022.1997600
Ameri, Mehrdad, et al. "The potential of intrinsically disordered regions in vaccine development." Expert review of vaccines vol. 21,1 (2022): 1-3. doi: https://doi.org/10.1080/14760584.2022.1997600
Ameri M, Nezafat N, Eskandari S. The potential of intrinsically disordered regions in vaccine development. Expert Rev Vaccines. 2022 Jan;21(1):1-3. doi: 10.1080/14760584.2022.1997600. Epub 2021 Nov 15. PMID: 34693831.
Copy Download .nbib Format: NLM
Prevalence of Multiple sclerosis and its clinical and demographic characteristics in Kurdish populations in western Iran (2020).

Multiple sclerosis and related disorders

Razazian N, Eskandarieh S, Siabani S, Afshari D, Sahraian MA, Khezri O, Rezaei M, Fakhri N.
PMID: 34896874
Mult Scler Relat Disord. 2021 Dec 04;57:103441. doi: 10.1016/j.msard.2021.103441. Epub 2021 Dec 04.

BACKGROUND: Multiple Sclerosis (MS) is a costly burdensome nervous system disorder leading several disabilities in young and middle-aged people. Knowing MS clinical, epidemiologic and demographic characteristics may help to estimate and predict the required health services and medication facilities...

Cite
Razazian N, Eskandarieh S, Siabani S, et al. Prevalence of Multiple sclerosis and its clinical and demographic characteristics in Kurdish populations in western Iran (2020). Mult Scler Relat Disord. 2021;57:103441doi: 10.1016/j.msard.2021.103441.
Razazian, N., Eskandarieh, S., Siabani, S., Afshari, D., Sahraian, M. A., Khezri, O., Rezaei, M., & Fakhri, N. (2021). Prevalence of Multiple sclerosis and its clinical and demographic characteristics in Kurdish populations in western Iran (2020). Multiple sclerosis and related disorders, 57103441. https://doi.org/10.1016/j.msard.2021.103441
Razazian, Nazanin, et al. "Prevalence of Multiple sclerosis and its clinical and demographic characteristics in Kurdish populations in western Iran (2020)." Multiple sclerosis and related disorders vol. 57 (2021): 103441. doi: https://doi.org/10.1016/j.msard.2021.103441
Razazian N, Eskandarieh S, Siabani S, Afshari D, Sahraian MA, Khezri O, Rezaei M, Fakhri N. Prevalence of Multiple sclerosis and its clinical and demographic characteristics in Kurdish populations in western Iran (2020). Mult Scler Relat Disord. 2021 Dec 04;57:103441. doi: 10.1016/j.msard.2021.103441. Epub 2021 Dec 04. PMID: 34896874.
Copy Download .nbib Format: NLM
Prevalence of Multiple sclerosis and its clinical and demographic characteristics in Kurdish populations in western Iran (2020).

Multiple sclerosis and related disorders

Razazian N, Eskandarieh S, Siabani S, Afshari D, Sahraian MA, Khezri O, Rezaei M, Fakhri N.
PMID: 34896874
Mult Scler Relat Disord. 2021 Dec 04;57:103441. doi: 10.1016/j.msard.2021.103441. Epub 2021 Dec 04.

BACKGROUND: Multiple Sclerosis (MS) is a costly burdensome nervous system disorder leading several disabilities in young and middle-aged people. Knowing MS clinical, epidemiologic and demographic characteristics may help to estimate and predict the required health services and medication facilities...

Cite
Razazian N, Eskandarieh S, Siabani S, et al. Prevalence of Multiple sclerosis and its clinical and demographic characteristics in Kurdish populations in western Iran (2020). Mult Scler Relat Disord. 2021;57:103441doi: 10.1016/j.msard.2021.103441.
Razazian, N., Eskandarieh, S., Siabani, S., Afshari, D., Sahraian, M. A., Khezri, O., Rezaei, M., & Fakhri, N. (2021). Prevalence of Multiple sclerosis and its clinical and demographic characteristics in Kurdish populations in western Iran (2020). Multiple sclerosis and related disorders, 57103441. https://doi.org/10.1016/j.msard.2021.103441
Razazian, Nazanin, et al. "Prevalence of Multiple sclerosis and its clinical and demographic characteristics in Kurdish populations in western Iran (2020)." Multiple sclerosis and related disorders vol. 57 (2021): 103441. doi: https://doi.org/10.1016/j.msard.2021.103441
Razazian N, Eskandarieh S, Siabani S, Afshari D, Sahraian MA, Khezri O, Rezaei M, Fakhri N. Prevalence of Multiple sclerosis and its clinical and demographic characteristics in Kurdish populations in western Iran (2020). Mult Scler Relat Disord. 2021 Dec 04;57:103441. doi: 10.1016/j.msard.2021.103441. Epub 2021 Dec 04. PMID: 34896874.
Copy Download .nbib Format: NLM
Characteristics of COVID-19 in patients with multiple sclerosis.

Multiple sclerosis and related disorders

Ghadiri F, Sahraian MA, Shaygannejad V, Ashtari F, Ghalyanchi H, Baghbanian SM, Mojdehipanah H, Majdi-Nasab N, Hosseini S, Poursadeghfard M, Beladimoghadam N, Razazian N, Ayoubi S, Rezaeimanesh N, Eskandarieh S, Naser Moghadasi A.
PMID: 34896875
Mult Scler Relat Disord. 2021 Nov 30;57:103437. doi: 10.1016/j.msard.2021.103437. Epub 2021 Nov 30.

BACKGROUND: Regarding the high prevalence of multiple sclerosis (MS) and COVID-19 in Iran, a multicenter study of COVID-19 in Iranian MS patients with is carried out to address the concerns of this population.METHODS: Data on MS patients with COVID-19...

Cite
Ghadiri F, Sahraian MA, Shaygannejad V, et al. Characteristics of COVID-19 in patients with multiple sclerosis. Mult Scler Relat Disord. 2021;57:103437doi: 10.1016/j.msard.2021.103437.
Ghadiri, F., Sahraian, M. A., Shaygannejad, V., Ashtari, F., Ghalyanchi, H., Baghbanian, S. M., Mojdehipanah, H., Majdi-Nasab, N., Hosseini, S., Poursadeghfard, M., Beladimoghadam, N., Razazian, N., Ayoubi, S., Rezaeimanesh, N., Eskandarieh, S., & Naser Moghadasi, A. (2021). Characteristics of COVID-19 in patients with multiple sclerosis. Multiple sclerosis and related disorders, 57103437. https://doi.org/10.1016/j.msard.2021.103437
Ghadiri, Fereshteh, et al. "Characteristics of COVID-19 in patients with multiple sclerosis." Multiple sclerosis and related disorders vol. 57 (2021): 103437. doi: https://doi.org/10.1016/j.msard.2021.103437
Ghadiri F, Sahraian MA, Shaygannejad V, Ashtari F, Ghalyanchi H, Baghbanian SM, Mojdehipanah H, Majdi-Nasab N, Hosseini S, Poursadeghfard M, Beladimoghadam N, Razazian N, Ayoubi S, Rezaeimanesh N, Eskandarieh S, Naser Moghadasi A. Characteristics of COVID-19 in patients with multiple sclerosis. Mult Scler Relat Disord. 2021 Nov 30;57:103437. doi: 10.1016/j.msard.2021.103437. Epub 2021 Nov 30. PMID: 34896875.
Copy Download .nbib Format: NLM
Characteristics of COVID-19 in patients with multiple sclerosis.

Multiple sclerosis and related disorders

Ghadiri F, Sahraian MA, Shaygannejad V, Ashtari F, Ghalyanchi H, Baghbanian SM, Mojdehipanah H, Majdi-Nasab N, Hosseini S, Poursadeghfard M, Beladimoghadam N, Razazian N, Ayoubi S, Rezaeimanesh N, Eskandarieh S, Naser Moghadasi A.
PMID: 34896875
Mult Scler Relat Disord. 2021 Nov 30;57:103437. doi: 10.1016/j.msard.2021.103437. Epub 2021 Nov 30.

BACKGROUND: Regarding the high prevalence of multiple sclerosis (MS) and COVID-19 in Iran, a multicenter study of COVID-19 in Iranian MS patients with is carried out to address the concerns of this population.METHODS: Data on MS patients with COVID-19...

Cite
Ghadiri F, Sahraian MA, Shaygannejad V, et al. Characteristics of COVID-19 in patients with multiple sclerosis. Mult Scler Relat Disord. 2021;57:103437doi: 10.1016/j.msard.2021.103437.
Ghadiri, F., Sahraian, M. A., Shaygannejad, V., Ashtari, F., Ghalyanchi, H., Baghbanian, S. M., Mojdehipanah, H., Majdi-Nasab, N., Hosseini, S., Poursadeghfard, M., Beladimoghadam, N., Razazian, N., Ayoubi, S., Rezaeimanesh, N., Eskandarieh, S., & Naser Moghadasi, A. (2021). Characteristics of COVID-19 in patients with multiple sclerosis. Multiple sclerosis and related disorders, 57103437. https://doi.org/10.1016/j.msard.2021.103437
Ghadiri, Fereshteh, et al. "Characteristics of COVID-19 in patients with multiple sclerosis." Multiple sclerosis and related disorders vol. 57 (2021): 103437. doi: https://doi.org/10.1016/j.msard.2021.103437
Ghadiri F, Sahraian MA, Shaygannejad V, Ashtari F, Ghalyanchi H, Baghbanian SM, Mojdehipanah H, Majdi-Nasab N, Hosseini S, Poursadeghfard M, Beladimoghadam N, Razazian N, Ayoubi S, Rezaeimanesh N, Eskandarieh S, Naser Moghadasi A. Characteristics of COVID-19 in patients with multiple sclerosis. Mult Scler Relat Disord. 2021 Nov 30;57:103437. doi: 10.1016/j.msard.2021.103437. Epub 2021 Nov 30. PMID: 34896875; PMCID: PMC8629769.
Copy Download .nbib Format: NLM
Showing 73 to 81 of 81 entries